| 000 | 01186 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516070726.0 | ||
| 264 | 0 | _c20120409 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1756-8927 | ||
| 024 | 7 |
_a10.4155/fmc.11.175 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWęsierska-Gądek, Józefa | |
| 245 | 0 | 0 |
_aTherapeutic intervention by the simultaneous inhibition of DNA repair and type I or type II DNA topoisomerases: one strategy, many outcomes. _h[electronic resource] |
| 260 |
_bFuture medicinal chemistry _cJan 2012 |
||
| 300 |
_a51-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDNA Repair |
| 650 | 0 | 4 | _aGenes, BRCA1 |
| 650 | 0 | 4 | _aGenes, BRCA2 |
| 650 | 0 | 4 | _aGenomic Instability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aTopoisomerase I Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aTopoisomerase II Inhibitors _xpharmacology |
| 700 | 1 | _aSkładanowski, Andrzej | |
| 773 | 0 |
_tFuture medicinal chemistry _gvol. 4 _gno. 1 _gp. 51-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4155/fmc.11.175 _zAvailable from publisher's website |
| 999 |
_c21390542 _d21390542 |
||